Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes

PLoS Pathogens

Volumn 5, Issue 1, 2009, Pages

  Walters, Kathie Anne ^a   Syder, Andrew J ^b   Lederer, Sharon L ^a   Diamond, Deborah L ^a   Paeper, Bryan ^a   Rice, Charles M ^b   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENOME ANALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CULTURE; LIVER TRANSPLANTATION; NONHUMAN; VIRUS LOAD; VIRUS REPLICATION; CELL CULTURE; CELL CYCLE; CYTOLOGY; GENETICS; LIVER CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

HEPATITIS C VIRUS;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINES; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; LIVER TRANSPLANTATION;

EID: 59249089462     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000269     Document Type: Article

References (52)

1. Alter MJH, Margolis HS, Krawczynski K, Judson F, Mares A, et al. (1992) The natural history of community-acquired hepatitis C in the United States. N Engl J Med 321: 1494-1500.
2. Nelson DR (2001) The immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 5: 931-953.
3. Mengshol JA, Golden-Mason L, Rosen HR (2007) Mechanisms of Disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol 4: 622-634.
4. Abel M, Sene D, Pol S, Bourliere M, Poynard T, et al. (2006) Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44: 1607-1616.
5. Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, et al. (2006) Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response. PLoS Pathog 2: e259. doi:10.1371/journal.ppat.0020059.
6. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
7. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
8. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, et al. (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A 103: 3805-3809.
9. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102: 9294-9299.
10. Bates S, Vousden KH (1996) p53 in signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev 6: 12-18.
11. Spurgers KB, Gold DL, Coombes KR, Bohnenstiehl NL, Mullins B, et al. (2006) Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression. J Biol Chem 281: 25134-25142.
12. Robinson M, Jiang P, Cui J, Li J, Wang Y, et al. (2003) Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells. Cancer Biol Ther 2: 406-415.
13. Lee KY, Bae SC (2002) TGF-beta-dependent cell growth arrest and apoptosis. J Biochem Mol Biol 35: 47-53.
14. Schuster N, Krieglstein K (2002) Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 307: 1-14.
15. Dupont S, Zacchigna L, Adorno M, Soligo S, Volpin D, et al. (2004) Convergence of p53 and TGF-beta signaling networks. Cancer Lett 213: 129-138.
16. Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, et al. (2001) Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 75: 4321-4331.
17. Wieland S, Thimme R, Purcell RH, Chisari FV (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101: 6669-6674.
18. Doughty AL, Spencer JD, Cossart YE, McCaughan GW (1998) Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg 4: 15-21.
19. Pelletier SJ, Raymond DP, Crabtree TD, Berg CL, Iezzoni JC, et al. (2000) Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology 32: 418-426.
20. Di MV, Saurini F, Samuel D, Gigou M, Dussaix E, Reynes M, et al. (1997) Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 26: 1343-1350.
21. Pal S, Shuhart MC, Thomassen L, Emerson SS, Su T, et al. (2006) Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo. J Virol 80: 2280-2290.
22. Marshall A, Rushbrook S, Morris LS, Scott IS, Vowler SL, et al. (2005) Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: a pilot study. Liver Transpl 11: 427-433.
23. Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, et al. (2005) Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 128: 33-42.
24. Bostik P, Dodd GL, Villinger F, Mayne AE, Ansari AA (2004) Perturbation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection. J Virol 78: 1464-1472.
25. Paiardini M, Cervasi B, Dunham R, Sumpter B, Radziewicz H, et al. (2004) Cell-cycle perturbation in the immunopathogenesis of AIDS. Immunol Res 29: 253-268.
26. Paiardini M, Cervasi B, Sumpter B, McClure HM, Sodora DL, et al. (2006) Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys. J Virol 80: 634-642.
27. Park US, Park SK, Lee YI, Park JG, Lee YI (2000) Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1->S transition via a p53-independent pathway in human hepatoma cells. Oncogene 19: 3384-3394.
28. Shostak LD, Ludlow J, Fisk J, Pursell S, Rimel BJ, et al. (1999) Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp Cell Res 251: 156-165.
29. Nguyen H, Mudryj M, Guadalupe M, Dandekar S (2003) Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle. Virology %20 312: 245-253.
30. Ohkawa K, Ishida H, Nakanishi F, Hosui A, Ueda K, et al. (2004) Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression. J Biol Chem 279: 11719-11726.
31. Yao ZQ, Eisen-Vandervelde A, Ray S, Hahn YS (2003) HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1. Virology 314: 271-282.
32. Yang XJ, Liu J, Ye L, Liao QJ, Wu JG, et al. (2006) HCV NS2 protein inhibits cell proliferation and induces cell cycle arrest in the S-phase in mammalian cells through down-regulation of cyclin A expression. Virus Res 121: 134-143.
33. Naka K, Dansako H, Kobayashi N, Ikeda M, Kato N (2006) Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 346: 348-362.
34. Baek KH, Park HY, Kang CM, Kim SJ, Jeong SJ, et al. (2006) Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle perturbation. J Mol Biol 359: 22-34.
35. Sainz B Jr, Chisari FV (2006) Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J Virol 80: 10253-10257.
36. Nelson HB, Tang H (2006) Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression. J Virol 80: 1181-1190.
37. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, et al. (2002) Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122: 366-375.
38. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, et al. (2006) Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 80: 7199-7207.
39. Korenaga M, Wang T, Li Y, Showalter LA, Chan T, et al. (2005) Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280: 37481-37488.
40. Tang W, Lazaro CA, Campbell JS, Parks WT, Katze MG, et al. (2007) Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame. Am J Pathol 171: 1831-1846.
41. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM (2002) Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316: 83-94.
42. Calabrese F, Valente M, Giacometti C, Pettenazzo E, Benvegnu L, et al. (2003) Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology. J Gastroenterol Hepatol 18: 1302-1308.
43. Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, et al. (1997) Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat 4: 29-35.
44. Smith MW, Walters K-A, Korth MJ, Fitzgibbon M, Proll SC, et al. (2006) Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterol 130: 179-187.
45. Teixeira R, Marcos LA, Friedman SL (2007) Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C. Hepatol Res 37: 579-595.
46. Sekine-Osajima Y, Sakamoto N, Mishima K, Nakagawa M, Itsui Y, et al. (2008) Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity. Virology 371: 71-85.
47. Deng L, Adachi T, Kitayama K, Bungyoku Y, Kitazawa S, et al. (2008) Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol 82: 10375-10385.
48. Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, et al. (2007) Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133: 1649-1659.
49. Sarfraz S, Hamid S, Siddiqui A, Hussain S, Pervez S, et al. (2008) Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infection. BMC Microbiol 8: 133.
50. Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19: 1409-1417.
51. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME) toward standards for microarray data. Nature Genet 29: 365-371.
52. Mayerat C, Burgisser P, Lavanchy D, Mantegani A, Frei PC (1996) Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation. J Clin Microbiol 34: 2702-2706.